PoltregWAR:PTG +1.86%46 Days Payable is 83.85 as of Mar. 2026, which is 77% below its 10-year median of 362.00. GuruFocus rates WAR:PTG with a GF Score™ of 46/100 and a GF Value™ of zł14.20 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 701 Biotechnology companies, Poltreg ranks worse than 52.07% on this metric.
Poltreg's average Accounts Payable for the
three
months ended in Mar. 2026 was zł1.24 Mil. Poltreg's Cost of Goods Sold for the
three
months ended in Mar. 2026 was zł1.35 Mil.
Hence, Poltreg's Days Payable for the
three
months ended in Mar. 2026 was 83.85.
The historical rank and industry rank for Poltreg's Days Payable or its related term are showing as below:
WAR:PTG'
s Days Payable Range Over the Past 10 Years
Min: 67.21 Med: 362 Max: 921.19
Current: 101.89
During the past 8 years, Poltreg's highest Days Payable was 921.19. The lowest was 67.21. And the median was 362.00.
WAR:PTG's Days Payable is ranked worse than 52.07% of 701
companies
in the Biotechnology industry
Industry Median: 112.84
vs WAR:PTG: 101.89
Poltreg's Days Payable
declined
from Mar. 2025 (99.32) to Mar. 2026 (83.85).
It may suggest that Poltregaccelerated paying its suppliers.
Poltreg Days Payable Related Terms
Poltreg Days Payable Historical Data
* Premium members only.
The historical data trend for Poltreg's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:PTG vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Poltreg's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poltreg Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Poltreg's Days Payable distribution charts can be found below:
* The bar in red indicates where Poltreg's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Poltreg's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poltreg (WAR:PTG) has a Days Payable of 83.85 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Poltreg and its competitors. This is 77% below median its historical median of 362.00. Over the past decade, Poltreg's Days Payable has ranged from 67.21 to 921.19. According to the industry distribution chart, Poltreg ranks #365 out of 701 companies in the Biotechnology industry, placing it in the top 52.1%.
Is Poltreg's Days Payable too high?
Poltreg's current Days Payable of 83.85 is 77% below median its 10-year median of 362.00. Over the past 10 years, this metric has ranged from a low of 67.21 to a high of 921.19. The Biotechnology industry median Days Payable is 112.84. Poltreg's value of 83.85 is 25.7% below this industry median. Based on the distribution chart, Poltreg ranks #365 out of 701 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Poltreg has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Poltreg ranks #365 out of 701 companies for Days Payable. This places Poltreg in the lower half of its industry. The industry median Days Payable is 112.84. Poltreg's value of 83.85 is 25.7% below this benchmark. Historically, Poltreg's own Days Payable has ranged from 67.21 to 921.19 over the past decade. While the company's 10-year median is 362.00 vs. the industry median of 112.84, Poltreg has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poltreg's current Days Payable of 83.85 is 25.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Poltreg and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poltreg's current Days Payable is 83.85, which is 77% below median its own 10-year median of 362.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł19.15 — trading 34.9% above its estimated fair value. The current Days Payable is 83.85, which is 77% below median its 10-year median of 362.00 and 25.7% below the Biotechnology industry median of 112.84. Poltreg's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current Days Payable is 83.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poltreg (WAR:PTG) Overvalued in 2026?
Based on GuruFocus' analysis, Poltreg stock appears to be overvalued.
The current stock price of zł19.15 is trading 34.9% above its estimated GF Value™ of zł14.20.
GuruFocus considers Poltreg to be Significantly Overvalued.
Key valuation signals for WAR:PTG:
Days Payable: 83.85 (77% below median its 10-year median of 362.00)
GF Value™: zł14.20 vs. price of zł19.15 (34.9% above fair value)
Industry Position: 25.7% below the Biotechnology median (#365 of 701)
No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score
Get the complete analysis for WAR:PTG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PTG has been successfully added to your 
